ClinicalTrials.gg
CompletedNCT07856992Updated Oct 5, 2026

Therapeutic Exercise Plus Pain Neuroscience Education for Chronic Low Back Pain

An interventional study of Therapeutic exercise and Pain Neuroscience Education in Chronic Low-back Pain (cLBP), sponsored by Qingdao Municipal Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Qingdao Municipal Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2025, registered Sep 2026).
Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 49 studies in Low Back Pain with a site in China — 17 open to participants now, 19 under way, none of them phase 3. Low Back Pain · China.

Enrollment
29th of 42
60 · median 84
Started
2025
with 5 others
No phase
36 of 49
14 open now
Registered
48th of 49
by date

Among the 49 studies in Low Back Pain with a site in China, this one is the 29th largest by enrollment of the 42 interventional ones that give a count, is one of 6 that started in 2025, is one of 36 with no phase, and was the 48th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

17 of the 49 studies in Low Back Pain with a site in China are open now. Recruiting first, the newest first:

12 more — sign in →

All 17 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 49 studies in Low Back Pain with a site in China, or all of them as a file.
02

Study summary

### What is this study about?

This study looked at whether adding **pain neuroscience education (PNE)** to standard therapeutic exercise helps people with chronic low back pain who are afraid of moving (a condition called *kinesiophobia*).

### Why does it matter?

Chronic low back pain is the leading cause of disability worldwide. Many people with chronic back pain develop fear of movement, which makes them avoid exercise and can slow down recovery. While exercise is the recommended first-line treatment, fear of movement often reduces how much patients benefit from it.

Pain neuroscience education is a talking therapy that helps patients understand that chronic pain is not always a sign of tissue damage - it often involves the nervous system becoming overly sensitive. The idea is that changing how patients think about pain may reduce their fear and help them engage more fully in exercise.

### What did the researchers do?

Patients with chronic low back pain and high fear of movement were randomly assigned to two groups

  • **Group 1:** 8 weeks of therapeutic exercise alone
  • **Group 2:** 8 weeks of therapeutic exercise **plus** two pain neuroscience education sessions (at the start and at week 4)
  • Patients were assessed at **baseline, 8 weeks, and 24 weeks** (6-month follow-up)
  • Measures included: fear of movement (TSK-17), pain intensity (NRS), disability (RMDQ), pain catastrophizing (PCS), and central sensitization symptoms (CSI)
  • Brain scans (resting-state fMRI) were taken before and after the intervention to explore potential brain-behavior links
03

Conditions studied

  • Chronic Low-back Pain (cLBP)

Browse trials for

Keywords

  • chronic low back pain
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-65 years
  • Chronic non-specific low back pain (CLBP) lasting ≥3 months
  • Numerical Rating Scale (NRS) score ≥3
  • Tampa Scale for Kinesiophobia (TSK-17) score ≥37
  • Right-handed
  • Able to complete all clinical and magnetic resonance imaging (MRI) assessments

Exclusion criteria

Exclusion Criteria:

  • Specific low back pain caused by tumor, infection, fracture, or inflammatory disease
  • Previous lumbar surgery
  • Severe neurological or psychiatric disorders
  • to MRI
  • Participation in other structured rehabilitation programs during the study period
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    pain neuroscience education plus therapeutic exercise (PNE+TE) group

    Behavioral: Therapeutic exercise · Behavioral: Pain Neuroscience Education

  • Active comparator
    therapeutic exercise (TE) group

    Behavioral: Therapeutic exercise

Interventions

  • BehavioralTherapeutic exercise

    \*\*Therapeutic Exercise (TE)\*\* is a structured, supervised program of physical activities designed to improve strength, flexibility, motor control, and functional capacity in patients with musculoskeletal conditions such as chronic low back pain. In this study, the TE program combined three components: motor control exercises (e.g., transversus abdominis and multifidus activation to stabilize the lumbar spine), stretching exercises (e.g., piriformis and erector spinae stretches), and low-intensity aerobic training (daily walking). It was delivered in two supervised face-to-face sessions (at baseline and week 4) with prescribed home exercises performed twice daily, and served as the active control condition that both study groups received-with the experimental group additionally receiving pain neuroscience education.

  • BehavioralPain Neuroscience Education

    \*\*Pain Neuroscience Education (PNE)\*\* is a non-pharmacological, educational intervention that helps people with chronic pain reconceptualize their understanding of pain. Through structured discussions and visual materials, a trained therapist explains that chronic pain is often not a reliable sign of ongoing tissue damage but rather a result of heightened nervous system sensitivity, and that psychological factors such as fear, stress, and negative beliefs can amplify pain perception. The goal is to correct misconceptions about pain, reduce fear of movement (kinesiophobia), and encourage patients to engage more fully in exercise and rehabilitation-rather than directly treating pain through manual therapy, medication, or exercise itself.

06

What researchers measure

Primary outcomes

  1. TSK-17

    TSK-17, full name Tampa Scale of Kinesiophobia-17, ranges from 17 to 68, and a higher score indicates worse kinesiophobia.

    Time frame: TSK-17 was administered at baseline, 8 weeks, 24 weeks.

Secondary outcomes

  1. Numerical Rating Scale

    NRS, full name Numeric Rating Scale, ranges from 0 to 10, and a higher score indicates greater pain intensity.

    Time frame: at baseline, 8 weeks, 24 weeks

  2. Roland-Morris Disability Questionnaire

    RMDQ, full name Roland-Morris Disability Questionnaire, ranges from 0 to 24, and a higher score indicates more severe low back pain-related disability.

    Time frame: at baseline, 8 weeks, 24 weeks

  3. Pain Catastrophizing Scale

    PCS, full name Pain Catastrophizing Scale, ranges from 0 to 52, and a higher score indicates stronger pain catastrophizing.

    Time frame: at baseline, 8 weeks, 24 weeks

  4. Central Sensitization Inventory

    CSI, full name Central Sensitization Inventory, ranges from 0 to 100, and a higher score indicates more prominent central sensitization symptoms.

    Time frame: at baseline, 8 weeks, 24 weeks

  5. Fractional amplitude of low-frequency fluctuations

    Time frame: at baseline, 8 weeks

  6. regional homogeneity (ReHo)

    Time frame: at baseline, 8 weeks

07

Study locations

1 site
  • Qingdao Municipal Hospital
    Qingdao, Shandong 266001, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Oct 2025, 9 months.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's 9 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2026
First posted
Oct 5, 2026
StartActual
Jan 6, 2025
Primary completionActual
Oct 15, 2025
CompletionActual
Oct 15, 2025
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07856992
Lead sponsor
Qingdao Municipal Hospital
Responsible party
Zichao Zhang (Junior Physical Therapist, Qingdao Municipal Hospital) — Principal investigator
First posted
Oct 5, 2026
Start date
Jan 6, 2025
Primary completion
Oct 15, 2025
Completion
Oct 15, 2025
Last update
Oct 5, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion